Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.
1/5 보강
OpenAlex 토픽 ·
Prostate Cancer Diagnosis and Treatment
Prostate Cancer Treatment and Research
BRCA gene mutations in cancer
APA
Sarah Wakerell, Questa Karlsson, et al. (2026). Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.. Genome medicine. https://doi.org/10.1186/s13073-026-01640-y
MLA
Sarah Wakerell, et al.. "Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.." Genome medicine, 2026.
PMID
42001130 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese.
- Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.
- Multigene Germline Panel Testing in Gastric Cancer Patients in a Portuguese Population.
- Are There Socio-Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review.
- Personalized Decision-Making in Risk-Reducing Surgery of the Ovaries.
- Case Report: A combination of and high polygenic risk score leads to early-onset male breast cancer.